ERGOMED PLC (2EM.DE) Forecast, Price Target & Analyst Ratings
FRA:2EM • GB00BN7ZCY67
11 EUR
-0.42 (-3.68%)
Last: Mar 31, 2023, 07:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ERGOMED PLC (2EM.DE).
Forecast Snapshot
Consensus Price Target
€16.93
+ 53.90% Upside
Next Earnings Forecast
Release DateN/A
ChartMill Buy Consensus
85.00%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
€16.93
Upside
+ 53.90%
From current price of €11.00 to mean target of €16.93, Based on 12 analyst forecasts
Low
€15.63
Median
€16.89
High
€19.19
Price Target Revisions
1 Month
1.96%
3 Months
4.14%
Price Target Summary
12 Wall Street analysts provided a forecast for the next 12 months for 2EM.DE. The average price target is 16.93 EUR. This implies a price increase of 53.9% is expected in the next year compared to the current price of 11.
The average price target has been revised upward by 4.14% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
85.00%
2EM.DE was analyzed by 12 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about 2EM.DE.
In the previous month the buy percentage consensus was at a similar level.
2EM.DE was analyzed by 12 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2021-06-10 | Shore Capital | Reiterate | No Recommendation |
| 2021-05-17 | Numis | Upgrade | Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateN/A
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 86.391M 26.57% | 118.581M 37.26% | 145.262M 22.50% | 163.45M 12.52% | 181.7M 11.17% | 196.64M 8.22% | 208.45M 6.01% | 224.1M 7.51% | 238.66M 6.50% | 253.92M 6.39% | 269.32M 6.06% | |
| EBITDA YoY % growth | 19.23M 65.43% | 24.395M 26.86% | 26.38M 8.14% | 32.775M 24.24% | 36.969M 12.80% | 41.148M 11.30% | 44.631M 8.46% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 14.387M 81.84% | 19.349M 34.49% | 20.542M 6.17% | 28.024M 36.42% | 32.924M 17.49% | 36.829M 11.86% | 39.429M 7.06% | 39.936M 1.29% | 42.663M 6.83% | 44.319M 3.88% | 46.072M 3.96% | |
| Operating Margin | 16.65% | 16.32% | 14.14% | 17.15% | 18.12% | 18.73% | 18.92% | 17.82% | 17.88% | 17.45% | 17.11% | |
| EPS YoY % growth | N/A 50.69% | N/A 27.23% | N/A 23.66% | 0.47 15.11% | 0.53 14.25% | 0.60 13.15% | 0.62 3.74% | N/A | N/A | N/A | N/A |
All data in GBP
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in GBP
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
14.17%
EPS Next 5 Year
11.47%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
10.64%
Revenue Next 5 Year
9.07%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
20.29%
EBIT Next 5 Year
17.22%
ERGOMED PLC / 2EM.DE Forecast FAQ
What do analysts expect the price target to be for ERGOMED PLC (2EM.DE)?
12 analysts have analysed 2EM.DE and the average price target is 16.93 EUR. This implies a price increase of 53.9% is expected in the next year compared to the current price of 11.
Can you provide the expected long term growth rate for ERGOMED PLC stock?
The expected long term growth rate for ERGOMED PLC (2EM.DE) is 10.64%.